Unilever PLC: First Half 2024 Results Summary
Business Context and Reporting Period
This Form 6-K filing reports Unilever PLC's unaudited results for the six months ended June 30, 2024. The report highlights the execution of the "Growth Action Plan," focusing on high-quality sales growth, gross margin expansion, and the separation of the Ice Cream business, which is on track to complete by the end of 2025.
Key Financial Metrics
| Metric | H1 2024 | H1 2023 | Change |
|---|---|---|---|
| Turnover | €31.1 billion | €30.4 billion | +2.3% |
| Underlying Sales Growth (USG) | 4.1% | 3.0% | +110 bps |
| Underlying Operating Profit | €6.1 billion | €5.2 billion | +17.1% |
| Underlying Operating Margin | 19.6% | 17.1% | +250 bps |
| Net Profit | €4.0 billion | €3.9 billion | +3.5% |
| Diluted EPS | €1.47 | €1.40 | +5.4% |
| Underlying EPS | €1.62 | €1.39 | +16.3% |
| Free Cash Flow | €2.2 billion | €2.5 billion | -€0.3 billion |
| Net Debt | €25.2 billion | €23.7 billion | +€1.5 billion |
Material Changes vs. Prior Period
- Volume Growth: Underlying volume growth (UVG) improved to 2.6% in H1 2024, marking the third consecutive quarter of positive volume growth. Power Brands (approx. 75% of turnover) drove this with 4.0% volume growth.
- Margin Expansion: Gross margin improved by 420 basis points to 45.7%, driven by volume leverage, mix, and productivity. This allowed for a 180 basis point increase in brand and marketing investment to 15.1% of turnover.
- Segment Performance:
- Beauty & Wellbeing: Strongest performer with 7.1% USG, led by Health & Wellbeing and Prestige Beauty.
- Personal Care: 5.6% USG, driven by Deodorants and Skin Cleansing.
- Home Care: 3.3% USG with 4.6% volume growth, offset by negative price growth due to commodity deflation.
- Nutrition: 3.2% USG, driven by price with flat volumes in H1, though volumes turned positive in Q2.
- Ice Cream: Weakest performer with 0.6% USG and negative volume (-1.0%) due to a soft start to the season in Europe and weakness in China.
- Geography: Emerging markets grew 5.1% (USG), while Developed markets grew 2.8% (USG). Latin America and Africa/Turkey delivered double-digit growth.
Guidance, Outlook, and Risks
- 2024 Outlook: Unilever expects full-year 2024 Underlying Sales Growth (USG) to remain within the multi-year range of 3% to 5%, with the majority driven by volume. Underlying operating margin is expected to be at least 18% for the full year.
- Margin Progression: Management expects year-on-year margin progression in the second half to be smaller than in the first half, citing a low prior-year comparator and carry-over pricing effects that will not repeat.
- Capital Allocation: A €1.5 billion share buyback program was announced in February; the first tranche of €850 million commenced in May. The quarterly dividend was raised by 3.0% to €0.4396 per share.
- Risks and Contingencies:
- Russia: Operations represent ~1% of turnover. There remains a risk of asset write-downs or loss of profit if operations cannot continue.
- Hyperinflation: Significant net monetary losses arose from hyperinflationary economies (Argentina and Turkey).
- Geopolitics: Sales in Indonesia declined 5.7% due to consumer avoidance of multinational brands linked to the Middle East conflict.
Investor Verification Checklist
- Volume Sustainability: Verify if the 2.6% volume growth trend can be sustained in H2, particularly in the Ice Cream and Nutrition segments which faced headwinds.
- Margin Quality: Assess the durability of the 420bps gross margin improvement, noting management's warning that H2 progression will be smaller due to one-off factors.
- Ice Cream Separation: Monitor progress on the legal and operational separation of the Ice Cream business, targeted for completion by end-2025.
- Working Capital: Review the seasonal outflow in working capital that reduced Free Cash Flow to €2.2 billion despite strong operating profit.
- Indonesia Market: Evaluate the long-term impact of the geopolitical boycott on sales in Indonesia and potential recovery strategies.